Concepedia

A low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus a daunorubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia: A propensity score analysis

Daisuke Minakata, Shin‐ichiro Fujiwara, Shoko Ito, Kiyomi Mashima, Kento Umino, Hirofumi Nakano, Yasufumi Kawasaki, Miyuki Sugimoto, Ryoko Yamasaki, Chihiro Yamamoto,

Leukemia Research · 2016 · 14 citations · 21 references

DOI

Concepts

References

21

The central role of the propensity score in observational studies for causal effects

Paul R. Rosenbaum, Donald B. Rubin · Biometrika · 1983 · 31K citations · Full text

, , +16

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

Yoshinobu Kanda · Bone Marrow Transplantation · 2012 · 18.7K citations

, , +11

Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Hagop M. Kantarjian, Xavier Thomas, Anna Dmoszyńska et al. · Journal of Clinical Oncology · 2012 · 1.2K citations · Full text

, , +15

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

Hervé Dombret, John F. Seymour, Aleksandra Butrym et al. · Blood · 2015 · 1.1K citations · Full text

, , +2

Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program

Matthew J. Hayat, Nadia Howlader, Marsha E. Reichman et al. · The Oncologist · 2007 · 1.1K citations · Full text

, , +17